ISUPREL Solution for injection Ref.[8252] Active ingredients: Isoprenaline

Source: Medicines and Medical Devices Safety Authority (NZ)  Revision Year: 2019  Publisher: Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363

Product name and form

Isuprel 0.2 mg/mL Solution for injection.

Pharmaceutical Form

Solution for injection.

A colourless, sterile, non pyrogenic solution.

Qualitative and quantitative composition

Each mL of the sterile 1:5000 solution contains 0.2 mg of Isoprenaline hydrochloride.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Isoprenaline

Isoprenaline is a potent non selective beta-adrenergic agonist with low affinity for alphaadrenergic receptors. Isoprenaline acts primarily on the heart and on smooth muscle of bronchi, skeletal muscle vasculature and the gastrointestinal tract.
List of Excipients
  • Citric acid
  • Disodium edetate
  • Hydrochloric acid
  • Nitrogen
  • Sodium chloride
  • Sodium citrate dihydrate
  • Sodium hydroxide
  • Water for injection

Pack sizes and marketing

Injection, 200 microgram/1 mL ampoules: 25’s; 1 mg/5 mL ampoules: 10’s.

Marketing authorization holder

Pfizer New Zealand Limited, P O Box 3998, Auckland, New Zealand, 1140, Toll Free Number: 0800 736 363

Marketing authorization dates and numbers

31 Dec 1969

Drugs

Drug Countries
ISUPREL Estonia, France, United States
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈